$ACHV
ACHIEVE LIFE SCIENCES, INC.

2015 Q4 Form 10-K Financial Statement

#000156459016014302 Filed on March 09, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2014 Q4 2014 Q3
Revenue $6.024M $5.650M $4.800M
YoY Change 6.62% -34.3% -51.32%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.920M $2.730M $2.460M
YoY Change 6.96% 11.43% -0.4%
% of Gross Profit
Research & Development $6.587M $9.852M $9.586M
YoY Change -33.14% -25.34% -46.76%
% of Gross Profit
Depreciation & Amortization $60.00K $50.00K $60.00K
YoY Change 20.0% -28.57% 0.0%
% of Gross Profit
Operating Expenses $6.587M $9.852M $12.05M
YoY Change -33.14% -25.34% -33.1%
Operating Profit
YoY Change
Interest Expense $30.00K $20.00K $0.00
YoY Change 50.0% -33.33% -100.0%
% of Operating Profit
Other Income/Expense, Net $1.756M $983.0K $2.335M
YoY Change 78.64% 173.82% 316.22%
Pretax Income -$1.720M -$5.680M -$4.910M
YoY Change -69.72% -14.97% -51.14%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.722M -$5.682M -$4.907M
YoY Change -69.69% -14.91% -51.19%
Net Earnings / Revenue -28.59% -100.57% -102.23%
Basic Earnings Per Share
Diluted Earnings Per Share -$172.0M -$568.0M -$491.0M
COMMON SHARES
Basic Shares Outstanding 21.28M shares 21.14M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2014 Q4 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.94M $47.06M $54.00M
YoY Change -55.49% 20.04% 15.38%
Cash & Equivalents $67.00K $27.90M $48.95M
Short-Term Investments $20.88M $19.16M $5.100M
Other Short-Term Assets $14.00K $499.0K $2.500M
YoY Change -97.19% -91.4% -7.41%
Inventory
Prepaid Expenses
Receivables $0.00 $5.676M $4.827M
Other Receivables $100.0K $100.0K $0.00
Total Short-Term Assets $57.30M $55.76M $61.32M
YoY Change 2.76% 3.52% 2.69%
LONG-TERM ASSETS
Property, Plant & Equipment $600.0K $257.0K $312.0K
YoY Change 133.46% -35.26% -29.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $300.0K $273.0K $773.0K
YoY Change 9.89% -75.43% -34.21%
Total Long-Term Assets $902.0K $530.0K $1.336M
YoY Change 70.19% -70.91% -30.85%
TOTAL ASSETS
Total Short-Term Assets $57.30M $55.76M $61.32M
Total Long-Term Assets $902.0K $530.0K $1.336M
Total Assets $58.20M $56.29M $62.65M
YoY Change 3.39% 1.08% 1.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.300M $72.00K $1.562M
YoY Change 1705.56% -48.2% 3905.13%
Accrued Expenses $11.90M $15.70M $13.17M
YoY Change -24.2% 33.23% 16.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $200.0K $1.100M
YoY Change -50.0% -81.82% 0.0%
Total Short-Term Liabilities $20.66M $22.22M $20.93M
YoY Change -6.99% 48.77% 45.65%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $0.00 $2.900M
YoY Change -100.0% -21.62%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.0K $0.00 $2.900M
YoY Change -100.0% -21.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.66M $22.22M $20.93M
Total Long-Term Liabilities $100.0K $0.00 $2.900M
Total Liabilities $20.77M $22.23M $23.80M
YoY Change -6.58% 20.32% 31.52%
SHAREHOLDERS EQUITY
Retained Earnings -$176.8M -$160.0M -$154.3M
YoY Change 10.54% 19.65% 21.47%
Common Stock $211.6M $191.4M $190.5M
YoY Change 10.57% 13.75% 13.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.840M $34.06M $38.85M
YoY Change
Total Liabilities & Shareholders Equity $58.21M $56.29M $62.65M
YoY Change 3.41% 1.08% 1.64%

Cashflow Statement

Concept 2015 Q4 2014 Q4 2014 Q3
OPERATING ACTIVITIES
Net Income -$1.722M -$5.682M -$4.907M
YoY Change -69.69% -14.91% -51.19%
Depreciation, Depletion And Amortization $60.00K $50.00K $60.00K
YoY Change 20.0% -28.57% 0.0%
Cash From Operating Activities -$10.68M -$6.950M -$5.760M
YoY Change 53.67% -7.82% -43.7%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K $0.00 -$10.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.570M -$14.12M -$5.060M
YoY Change -118.2% -253.48% -214.74%
Cash From Investing Activities $2.500M -$14.12M -$5.070M
YoY Change -117.71% -253.81% -214.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $24.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 20.00K 19.17M
YoY Change -50.0%
NET CHANGE
Cash From Operating Activities -10.68M -6.950M -5.760M
Cash From Investing Activities 2.500M -14.12M -5.070M
Cash From Financing Activities 10.00K 20.00K 19.17M
Net Change In Cash -8.170M -21.05M 8.340M
YoY Change -61.19% -1383.54% -243.3%
FREE CASH FLOW
Cash From Operating Activities -$10.68M -$6.950M -$5.760M
Capital Expenditures -$70.00K $0.00 -$10.00K
Free Cash Flow -$10.61M -$6.950M -$5.750M
YoY Change 52.66% -7.58% -43.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55317000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-31849000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
20876000
CY2014Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
19160000
CY2014Q4 ogxi Lease Termination Liability Current
LeaseTerminationLiabilityCurrent
3250000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5040000
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3002000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22218000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14000
CY2015Q4 us-gaap Liabilities
Liabilities
20769000
CY2014Q4 us-gaap Liabilities
Liabilities
22232000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211590000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191373000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29846991
CY2014 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
27116000
CY2013 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
29882000
CY2014 ogxi Restructuring Costs Net
RestructuringCostsNet
267000
CY2013 us-gaap Operating Expenses
OperatingExpenses
65209000
CY2014 ogxi Warrant Issuance Costs
WarrantIssuanceCosts
531000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31843000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.17
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
66207000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2837000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37211000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3860000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
CY2014 ogxi Stock Issued During Period Value Performance Restricted Stock Unit Settlements Withheld And Retired To Treasury
StockIssuedDuringPeriodValuePerformanceRestrictedStockUnitSettlementsWithheldAndRetiredToTreasury
29000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14000
CY2015 ogxi Stock Issued During Period Value Performance Restricted Stock Unit Settlements Withheld And Retired To Treasury
StockIssuedDuringPeriodValuePerformanceRestrictedStockUnitSettlementsWithheldAndRetiredToTreasury
52000
CY2015 us-gaap Depreciation
Depreciation
244000
CY2014 us-gaap Depreciation
Depreciation
223000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22630652
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29812998
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22621426
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10829000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
738000
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-744000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2003000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
297000
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14683389
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
29000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-176811000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159958000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2622000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58209000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56291000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20664000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2632000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
37440000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
34059000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2328000
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1105000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
105000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2013 us-gaap Depreciation
Depreciation
227000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2834000
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-109000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7943000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1974000
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1190000
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
41000
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
7563000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
164000
CY2013 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-680000
CY2014 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
84000
CY2013 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
21000
CY2014 ogxi Increase Decrease In Lease Termination Fee
IncreaseDecreaseInLeaseTerminationFee
3250000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2328000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
3860000
CY2014 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
3517000
CY2015 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2000
CY2014 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-105000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5662000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2981000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1167000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3944000
CY2015 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1271000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-67000
CY2015 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
24368000
CY2014 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
19446000
CY2013 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
31696000
CY2015 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-222000
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
363000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3714000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2178000
CY2015 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-66000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-372000
CY2015 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
21000
CY2014 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
CY2015 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-194000
CY2014 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-785000
CY2015 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-100000
CY2015 ogxi Increase Decrease In Lease Termination Fee
IncreaseDecreaseInLeaseTerminationFee
-2000000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5040000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9101000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17308000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-35927000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
29000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22372000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
17591000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25247000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10000
CY2015 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1003000
CY2013 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1000000
CY2015 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
21659000
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24894000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
371000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-2077000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5366000
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
9000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
6413000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14593000
CY2015 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
218000
CY2013 ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
24000
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and notes thereto. Actual results could differ from these estimates. Estimates and assumptions principally relate to estimates of the fair value of our warrant liability, the initial fair value and forfeiture rates of stock options issued to employees and consultants, the estimated compensation cost on performance restricted stock unit awards and clinical trial and manufacturing accruals, estimated useful lives of property, plant and equipment and estimates and assumptions in contingent liabilities. </p></div>
CY2014 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P174D
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3002000
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
1897000
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
55458000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
47308000
CY2015Q4 us-gaap Cash
Cash
14034000
CY2015Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
55200000
CY2015 ogxi Maturity Period Of Highly Liquid Investments To Be Considered As Cash Equivalent
MaturityPeriodOfHighlyLiquidInvestmentsToBeConsideredAsCashEquivalent
P3M
CY2015 ogxi Description Of Maturity Period Of Financial Instruments To Be Considered As Short Term Investment
DescriptionOfMaturityPeriodOfFinancialInstrumentsToBeConsideredAsShortTermInvestment
Greater than three months and less than one year
CY2015 ogxi Amount To Be Spent In Direct And Indirect Development Costs Under Agreement
AmountToBeSpentInDirectAndIndirectDevelopmentCostsUnderAgreement
30000000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
30000000
CY2009 us-gaap Licenses Revenue
LicensesRevenue
22000000
CY2015 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2015 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P61D
CY2015Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
20885000
CY2015Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
9000
CY2014Q4 us-gaap Cash
Cash
16481000
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
19179000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000
CY2015 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2015 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1883000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1294000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1281000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1037000
CY2015Q1 ogxi Additional Contingent Liability Early Termination Of Lease Agreement
AdditionalContingentLiabilityEarlyTerminationOfLeaseAgreement
1300000
CY2015 ogxi Period Of Not Utilizing Prepaid Amounts Related To Clinical Trials
PeriodOfNotUtilizingPrepaidAmountsRelatedToClinicalTrials
P12M
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2015 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2014 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2013 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151910000
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151100000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5712000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8922000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
14000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
452000
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-13000
CY2014 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-9000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
689000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1445000
CY2015 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
-32000
CY2014 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
441000
CY2013 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
-10000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
357000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
347000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5114000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7854000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10538000
CY2015 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
265000
CY2013 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
127000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015Q4 ogxi Non Capital Gain Loss Carryforwards Amount
NonCapitalGainLossCarryforwardsAmount
100369000
CY2015 ogxi Unclaimed Tax Deductions Related To Scientific Research And Experimental Development Expenditures
UnclaimedTaxDeductionsRelatedToScientificResearchAndExperimentalDevelopmentExpenditures
14300000
CY2015 ogxi Tax Credit Carryforward Expiration Year Range Start
TaxCreditCarryforwardExpirationYearRangeStart
2016
CY2015 ogxi Tax Credit Carryforward Expiration Year Range End
TaxCreditCarryforwardExpirationYearRangeEnd
2035
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
6308000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
77746000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7484000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3448000
CY2015Q4 ogxi Deferred Tax Assets Liabilities Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsLiabilitiesTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
474000
CY2014Q4 ogxi Deferred Tax Assets Liabilities Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsLiabilitiesTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
-25000
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1627000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
97087000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
97087000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2039000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2007000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1967000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
16000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
32000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
32000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2055000
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2100000
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
100000
CY2014Q3 ogxi Net Proceeds Received From Offering After Deducting Underwriting Discounts And Offering Expenses
NetProceedsReceivedFromOfferingAfterDeductingUnderwritingDiscountsAndOfferingExpenses
22400000
CY2014Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
24000000
CY2014Q3 ogxi Warrant Issuance Costs
WarrantIssuanceCosts
1600000
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
5359
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3475
CY2015 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
269401
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2015Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2015 ogxi Indemnification Expense
IndemnificationExpense
0
CY2015Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
1374000
CY2015Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4025000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1479221
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1283419
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
502047
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
247766
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
53120
CY2014 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
203148
CY2013 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
47495
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0125
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.86
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.10
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.52
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.07
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
805281
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
239282
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3061
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30536
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1007491
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
382097
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12169
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.34
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.32
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.11
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.87
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.39
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.97
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
18.93
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.14
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.55
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.91
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.96
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.69
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.37
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1479221
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
8.78
CY2015 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y6M22D
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
846712
CY2015Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
11.93
CY2015 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P6Y6M11D
CY2015Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1800000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1900000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1800000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2787000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
51100000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
34000000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
350000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2015 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2015 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
One-for-eighteen reverse stock split
CY2015 ogxi Shareholder Rights Plan To Acquire Additional Shares Of Common Stock
ShareholderRightsPlanToAcquireAdditionalSharesOfCommonStock
0.15
CY2015 ogxi Number Of Rights Associated With Per Share Of Common Stock
NumberOfRightsAssociatedWithPerShareOfCommonStock
18
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5800000
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000
CY2015 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2014 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2013 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2015 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2016-09
CY2015Q3 ogxi Expansion Of Rental Space Notice Provided
ExpansionOfRentalSpaceNoticeProvided
2245
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
900000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
480000
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-423000
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
141000
CY2015Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1756000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4517000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-6010000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-4550000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-1722000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2014Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5653000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16903000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
11731000
CY2014Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4929000
CY2014Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4803000
CY2015Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6737000
CY2015Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6024000
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3673000
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6545000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8303000
CY2015Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6587000
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2698000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3067000
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3125000
CY2015Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2915000
CY2015Q1 us-gaap Costs And Expenses
CostsAndExpenses
6371000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
9612000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
11428000
CY2015Q4 us-gaap Costs And Expenses
CostsAndExpenses
9502000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9883000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9586000
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9852000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2757000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2676000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2459000
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2733000
CY2014Q4 us-gaap Restructuring Costs
RestructuringCosts
-267000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
12045000
CY2014Q4 us-gaap Costs And Expenses
CostsAndExpenses
12318000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2335000
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
983000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-4907000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-5682000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26

Files In Submission

Name View Source Status
0001564590-16-014302-index-headers.html Edgar Link pending
0001564590-16-014302-index.html Edgar Link pending
0001564590-16-014302.txt Edgar Link pending
0001564590-16-014302-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g201603082011545957556.jpg Edgar Link pending
g201603082011545957557.jpg Edgar Link pending
g201603082011547047558.jpg Edgar Link pending
g201603082011547207559.jpg Edgar Link pending
g201603082011547207560.jpg Edgar Link pending
g201603082011547367561.jpg Edgar Link pending
g201603082011547367562.jpg Edgar Link pending
g201603082011557677563.jpg Edgar Link pending
g201603082011568307564.jpg Edgar Link pending
g201603082012044157565.jpg Edgar Link pending
g201603082012057287566.jpg Edgar Link pending
ogxi-10k_20151231.htm Edgar Link pending
ogxi-20151231.xml Edgar Link completed
ogxi-20151231.xsd Edgar Link pending
ogxi-20151231_cal.xml Edgar Link unprocessable
ogxi-20151231_def.xml Edgar Link unprocessable
ogxi-20151231_lab.xml Edgar Link unprocessable
ogxi-20151231_pre.xml Edgar Link unprocessable
ogxi-ex211_11.htm Edgar Link pending
ogxi-ex231_10.htm Edgar Link pending
ogxi-ex311_9.htm Edgar Link pending
ogxi-ex312_7.htm Edgar Link pending
ogxi-ex321_8.htm Edgar Link pending
ogxi-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending